| Literature DB >> 31776286 |
James W Austin1, Clarisa M Buckner1, Lela Kardava1, Wei Wang1, Xiaozhen Zhang1, Valerie A Melson1, Ryan G Swanson1, Andrew J Martins2, Julian Q Zhou3, Kenneth B Hoehn4, J Nicholas Fisk3, Yiannis Dimopoulos5, Alexander Chassiakos5, Sijy O'Dell5, Margery G Smelkinson6, Catherine A Seamon7, Richard W Kwan7, Michael C Sneller1, Stefania Pittaluga8, Nicole A Doria-Rose5, Adrian McDermott5, Yuxing Li9,10, Tae-Wook Chun1, Steven H Kleinstein3,4, John S Tsang2,11, Constantinos Petrovas5, Susan Moir12.
Abstract
Nearly all chronic human infections are associated with alterations in the memory B cell (MBC) compartment, including a large expansion of CD19hiT-bethi MBC in the peripheral blood of HIV-infected individuals with chronic viremia. Despite their prevalence, it is unclear how these B cells arise and whether they contribute to the inefficiency of antibody-mediated immunity in chronic infectious diseases. We addressed these questions by characterizing T-bet-expressing B cells in lymph nodes (LN) and identifying a strong T-bet signature among HIV-specific MBC associated with poor immunologic outcome. Confocal microscopy and quantitative imaging revealed that T-bethi B cells in LN of HIV-infected chronically viremic individuals distinctly accumulated outside germinal centers (GC), which are critical for optimal antibody responses. In single-cell analyses, LN T-bethi B cells of HIV-infected individuals were almost exclusively found among CD19hi MBC and expressed reduced GC-homing receptors. Furthermore, HIV-specific B cells of infected individuals were enriched among LN CD19hiT-bethi MBC and displayed a distinct transcriptome, with features similar to CD19hiT-bethi MBC in blood and LN GC B cells (GCBC). LN CD19hiT-bethi MBC were also related to GCBC by B cell receptor (BCR)-based phylogenetic linkage but had lower BCR mutation frequencies and reduced HIV-neutralizing capacity, consistent with diminished participation in GC-mediated affinity selection. Thus, in the setting of chronic immune activation associated with HIV viremia, failure of HIV-specific B cells to enter or remain in GC may help explain the rarity of high-affinity protective antibodies.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31776286 PMCID: PMC7479651 DOI: 10.1126/scitranslmed.aax0904
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956